Clinical Trial Update: Study of TRDC002 in the Diagnosis of Patients With PSMA-positive Prostate Cancer [Phase 1]

View source ↗

Summary

This document provides an update on a Phase 1 clinical trial of TRDC002 for diagnosing PSMA-positive prostate cancer. The trial is currently active but not recr…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Prostate Cancer

Drugs mentioned

• TRDC002

Snippet

Sponsor: C Ray Therapeutics | Conditions: Prostate Cancer | Phase 1 | Status: ACTIVE_NOT_RECRUITING